Literature DB >> 20569212

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.

Iker Sánchez-Navarro1, Angelo Gámez-Pozo, Manuel González-Barón, Alvaro Pinto-Marín, David Hardisson, Rocío López, Rosario Madero, Paloma Cejas, Marta Mendiola, Enrique Espinosa, Juan Angel Fresno Vara.   

Abstract

Recent reports demonstrate the feasibility of quantifying gene expression by using RNA isolated from blocks of formalin-fixed, paraffin-embedded (FFPE) tumor tissue. The development of molecular tests for clinical use based on archival materials would be of great utility in the search for and validation of important genes or gene expression profiles. In this study, we compared the performance of different normalization strategies in the correlation of quantitative data between fresh frozen (FF) and FFPE samples and analyzed the parameters that characterize such correlation for each gene. Total RNA extracted from FFPE samples presented a shift in raw cycle threshold (Cq) values that can be explained by its extensive degradation. Proper normalization can compensate for the effects of RNA degradation in gene expression measurements. We show that correlation between normalized expression values is better for moderately to highly expressed genes whose expression varies significantly between samples. Nevertheless, some genes had no correlation. These genes should not be included in molecular tests for clinical use based on FFPE samples. Our results could serve as a guide when developing clinical diagnostic tests based on RT-qPCR analyses of FFPE tissues in the coming era of treatment decision-making based on gene expression profiling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569212     DOI: 10.2144/000113388

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  28 in total

1.  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Authors:  Sofia Levva; Vassiliki Kotoula; Ioannis Kostopoulos; Kyriaki Manousou; Christos Papadimitriou; Kyriaki Papadopoulou; Sotiris Lakis; Kyriakos Koukoulias; Vasilios Karavasilis; George Pentheroudakis; Eufemia Balassi; Flora Zagouri; Ioannis G Kaklamanos; Dimitrios Pectasides; Evangelia Razis; Gerasimos Aravantinos; Pavlos Papakostas; Dimitrios Bafaloukos; Grigorios Rallis; Helen Gogas; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

2.  Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.

Authors:  George P Christophi; Tiffany Caza; Christopher Curtiss; Divya Gumber; Paul T Massa; Steve K Landas
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

3.  Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.

Authors:  Evelyne Lerut; Hendrik Van Poppel; Steven Joniau; Olivier Gruselle; Thierry Coche; Patrick Therasse
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease.

Authors:  George P Christophi; Rong Rong; Philip G Holtzapple; Paul T Massa; Steve K Landas
Journal:  Inflamm Bowel Dis       Date:  2012-03-29       Impact factor: 5.325

5.  Testing an aflatoxin B1 gene signature in rat archival tissues.

Authors:  B Alex Merrick; Scott S Auerbach; Patricia S Stockton; Julie F Foley; David E Malarkey; Robert C Sills; Richard D Irwin; Raymond R Tice
Journal:  Chem Res Toxicol       Date:  2012-05-04       Impact factor: 3.739

6.  An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.

Authors:  Iker Sánchez-Navarro; Angelo Gámez-Pozo; Alvaro Pinto; David Hardisson; Rosario Madero; Rocío López; Belén San José; Pilar Zamora; Andrés Redondo; Jaime Feliu; Paloma Cejas; Manuel González Barón; Juan Angel Fresno Vara; Enrique Espinosa
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

7.  Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.

Authors:  Christos Christodoulou; Georgios Oikonomopoulos; Georgia Angeliki Koliou; Ioannis Kostopoulos; Vassiliki Kotoula; Mattheos Bobos; George Pentheroudakis; George Lazaridis; Maria Skondra; Sofia Chrisafi; Angelos Koutras; Dimitrios Bafaloukos; Evangelia Razis; Kyriaki Papadopoulou; Pavlos Papakostas; Haralambos P Kalofonos; Dimitrios Pectasides; Pantelis Skarlos; Konstantine T Kalogeras; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2018 Nov-Dec       Impact factor: 4.069

8.  Stepwise kinetic equilibrium models of quantitative polymerase chain reaction.

Authors:  Gary Cobbs
Journal:  BMC Bioinformatics       Date:  2012-08-16       Impact factor: 3.169

9.  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

Authors:  George Pentheroudakis; Vassiliki Kotoula; Wendy De Roock; George Kouvatseas; Pavlos Papakostas; Thomas Makatsoris; Demetris Papamichael; Ioannis Xanthakis; Joseph Sgouros; Despina Televantou; Georgia Kafiri; Athanassios C Tsamandas; Evangelia Razis; Eleni Galani; Dimitrios Bafaloukos; Ioannis Efstratiou; Iliada Bompolaki; Dimitrios Pectasides; Nicholas Pavlidis; Sabine Tejpar; George Fountzilas
Journal:  BMC Cancer       Date:  2013-02-02       Impact factor: 4.430

10.  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).

Authors:  Vassiliki Kotoula; Dimitrios Krikelis; Vasilios Karavasilis; Triantafillia Koletsa; Anastasia G Eleftheraki; Despina Televantou; Christos Christodoulou; Stefanos Dimoudis; Ippokratis Korantzis; Dimitrios Pectasides; Konstantinos N Syrigos; Paris A Kosmidis; George Fountzilas
Journal:  BMC Cancer       Date:  2012-08-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.